Home » Medical Devices » Gamma Knife Devices Market

Gamma Knife Devices Market

Gamma Knife Devices Market By Product Type (Portable Gamma Knife Devices, Fixed Gamma Knife Devices); By Disease Indication (Brain Tumors, Arteriovenous Malformations (AVMs), Trigeminal Neuralgia, Movement Disorders, Others); By End-User (Hospitals, Specialized Clinics, Ambulatory Surgery Centers (ASCs)) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Gamma Knife Devices Market Size 2024	USD 543.91 million
Gamma Knife Devices Market, CAGR	5.20%
Gamma Knife Devices Market Size 2032	USD 858.36 million

Market Overview

The global Gamma Knife Devices market is projected to grow from USD 543.91 million in 2023 to USD 858.36 million by 2032, at a compound annual growth rate (CAGR) of 5.20%.

The global Gamma Knife Devices market is driven by the increasing prevalence of neurological disorders, such as brain tumors, trigeminal neuralgia, and arteriovenous malformations, which require precise and non-invasive treatments. Advances in medical technology, improving the accuracy and efficiency of Gamma Knife systems, are also fueling market growth. The growing preference for minimally invasive procedures, coupled with shorter recovery times and fewer side effects, enhances the adoption of Gamma Knife devices. Furthermore, rising awareness of early diagnosis and treatment options, particularly in emerging economies, contributes to market expansion. Technological innovations, such as robotic assistance and integration with imaging systems, are expected to further enhance the capabilities of Gamma Knife devices, providing more precise and targeted treatment. Additionally, government initiatives and investments in healthcare infrastructure are likely to support the market’s development in both developed and developing regions.

The global Gamma Knife devices market is witnessing significant growth across various regions, with North America and Europe leading the adoption due to advanced healthcare infrastructure and high demand for precise, minimally invasive treatments. In these regions, key players like Elekta AB, Varian Medical Systems, and Accuray Incorporated dominate the market, offering cutting-edge technologies and innovative treatment solutions. The Asia-Pacific region is emerging as a high-growth market, driven by increasing healthcare investments and a growing prevalence of neurological disorders in countries like Japan, China, and India. In this region, players such as Philips Healthcare and GE Healthcare are expanding their presence. Latin America and the Middle East & Africa are also showing potential, as governments in these regions focus on healthcare improvements and the adoption of advanced medical technologies. As Gamma Knife technology becomes more widely accepted, these regions are expected to see increased market penetration.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The global Gamma Knife devices market was valued at USD 543.91 million in 2023 and is expected to reach USD 858.36 million by 2032, growing at a CAGR of 5.20%.
Increasing prevalence of neurological disorders, including brain tumors and AVMs, is driving the demand for Gamma Knife technology.
Technological advancements, such as improved precision and reduced treatment time, are boosting adoption.
The rising demand for minimally invasive procedures and shorter recovery times is encouraging the use of Gamma Knife devices.
Competitive landscape features key players like Elekta AB, Varian Medical Systems, and Accuray, focusing on product innovation and strategic partnerships.
High costs of Gamma Knife systems and limited reimbursement policies in some regions pose significant market restraints.
North America and Europe lead the market, with Asia-Pacific showing rapid growth due to increasing healthcare investments and technological advancements.

Market Drivers

Increasing Prevalence of Neurological Disorders

The rising incidence of neurological conditions, such as brain tumors, arteriovenous malformations (AVMs), and other related disorders, is a major driver for the adoption of Gamma Knife technology. These conditions, which require precise, targeted treatment, have seen a significant increase in cases globally. For instance, the American Society of Clinical Oncology reported that in 2020, an estimated 308,102 people were diagnosed with a primary brain or spinal cord tumor worldwide. As the need for effective, non-invasive treatment options grows, Gamma Knife technology has emerged as a preferred solution for managing complex neurological disorders. The ability to treat these conditions with high precision has made Gamma Knife systems a vital tool in neurosurgery, leading to a steady market expansion.

Technological Advancements

Continuous advancements in Gamma Knife technology have enhanced its appeal to both patients and healthcare providers. Innovations such as improved imaging systems, better targeting precision, and reduced treatment times have made Gamma Knife procedures more effective and accessible. For instance, the latest generation of Gamma Knife, such as the Gamma Knife Esprit, offers enhanced precision and reduced treatment times, making it a preferred choice for treating brain tumors and other neurological conditions. These advancements have led to higher success rates and better outcomes for patients, which, in turn, has boosted the technology’s popularity. As more hospitals and medical centers incorporate the latest Gamma Knife systems into their treatment offerings, the market for this technology continues to grow.

Rising Demand for Minimally Invasive Procedures

There is a growing preference for minimally invasive procedures across the global healthcare landscape, and Gamma Knife surgery is at the forefront of this trend. Unlike traditional open surgery, Gamma Knife surgery involves no incisions, resulting in shorter recovery times and fewer side effects for patients. This makes it an attractive option, especially for the aging population and those seeking faster recovery. As more patients opt for less invasive treatments, the demand for Gamma Knife devices is expected to rise, further fueling market growth.

Government Initiatives and Healthcare Infrastructure Investments

Governments and healthcare organizations worldwide are making significant investments in upgrading healthcare infrastructure, including the installation of advanced medical equipment like Gamma Knife systems. These investments aim to improve treatment quality and increase access to advanced therapies, particularly in emerging markets. In addition, rising healthcare expenditure has enabled hospitals and clinics to afford state-of-the-art technologies, contributing to the growing adoption of Gamma Knife devices. This investment in healthcare infrastructure is creating new opportunities for the global Gamma Knife market.

Market Trends

Expanding Applications

Gamma Knife technology, traditionally used for neurological disorders, is now being explored for a broader range of applications. Its use has expanded beyond brain tumors and AVMs to treat conditions in other parts of the body and functional disorders such as Parkinson’s disease and epilepsy. As the technology’s capabilities improve, there is growing interest in using Gamma Knife for Stereotactic Radiosurgery (SRS) procedures for various types of tumors and other medical conditions. For instance, the Cleveland Clinic has reported successful use of Gamma Knife technology in treating functional disorders like trigeminal neuralgia and epilepsy. The expanding range of applications has opened new markets for Gamma Knife devices, further fueling their adoption in healthcare systems globally. This trend signifies an evolving role for Gamma Knife technology, enhancing its value and demand across multiple specialties.

Technological Advancements

Recent advancements in Gamma Knife technology have significantly enhanced its capabilities, driving its adoption. Improved precision in newer systems allows for more targeted treatments, reducing side effects and improving patient outcomes. These systems enable highly accurate tumor targeting, ensuring the treatment is confined to the affected area. Additionally, the reduced treatment time offered by advanced Gamma Knife models contributes to better patient experiences by minimizing the time spent in the treatment room. Alongside this, enhanced imaging capabilities, including integration with modern imaging technologies, enable more effective treatment planning and real-time monitoring, increasing the accuracy and safety of procedures. These technological innovations continue to make Gamma Knife systems more appealing to healthcare providers and patients, driving market growth.

Rising Demand for Minimally Invasive Procedures

The global preference for minimally invasive procedures is another key driver of the Gamma Knife market. Patients are increasingly seeking treatment options that offer shorter recovery times, reduced pain, and minimal scarring, all of which are characteristic of Gamma Knife surgery. These procedures are particularly attractive to the aging population, who may face more complicated recoveries from traditional surgeries. Additionally, from a healthcare system perspective, minimally invasive treatments can be more cost-effective in the long run, reducing hospital stays and associated costs. The growing demand for less invasive treatments is expected to continue to boost the adoption of Gamma Knife systems worldwide.

Emerging Markets and Healthcare Infrastructure Development

Emerging economies are rapidly expanding their healthcare infrastructure, leading to increased adoption of advanced medical technologies like Gamma Knife systems. As these countries invest in modern healthcare equipment, they are creating new opportunities for Gamma Knife adoption in regions that were previously underserved. For example, the Indian government has invested in Gamma Knife facilities at major hospitals to enhance neurosurgical care. Government initiatives aimed at improving healthcare access and quality in these regions further support this trend. With rising healthcare expenditures and a greater emphasis on upgrading treatment capabilities, countries in Asia, Latin America, and Africa are expected to contribute significantly to the market’s growth. This development in emerging markets is a critical factor in the global expansion of Gamma Knife technology, broadening its reach and availability.

Market Challenges Analysis

High Cost and Limited Reimbursement

The high cost of Gamma Knife systems remains a significant challenge for their widespread adoption, particularly in smaller hospitals and clinics, especially in developing countries. These advanced systems require substantial upfront investment for purchase and ongoing maintenance, which can be a financial barrier for healthcare facilities with limited budgets. For instance, a study conducted at India’s largest neurosurgery center found that the average cost per Gamma Knife radiosurgery procedure was approximately $2,469, with major costs attributed to machinery, equipment, and manpower. This high cost also translates into increased treatment expenses for patients, which may make Gamma Knife procedures unaffordable for many. Furthermore, in some regions, insurance coverage for Gamma Knife treatments may be limited or not fully reimbursed, further exacerbating accessibility issues. In countries where healthcare insurance coverage is insufficient, patients may face significant out-of-pocket expenses, hindering the widespread adoption of this technology. The combination of these financial challenges can limit the availability of Gamma Knife treatments, particularly in underserved regions with lower healthcare budgets and limited insurance coverage.

Complex Installation, Maintenance, and Competition from Alternatives

Gamma Knife systems require specialized installation and ongoing maintenance, which can be a challenge for healthcare facilities lacking the necessary expertise and resources. These systems often demand a highly trained workforce, including radiation oncologists, medical physicists, and technicians, which can be difficult to find, particularly in rural or less-developed areas. This shortage of skilled personnel, along with the complexity of installation, can lead to delays in the implementation of Gamma Knife programs and increased operational costs. Additionally, the growing competition from alternative minimally invasive therapies, such as CyberKnife and linear accelerator-based stereotactic radiosurgery (SRS), presents another hurdle for Gamma Knife adoption. These alternatives may offer similar treatment outcomes for conditions like brain tumors at a lower cost and may be more readily available in certain regions, posing a challenge to Gamma Knife’s market position. Regulatory hurdles also play a role, as the approval processes for new Gamma Knife systems can be time-consuming and costly, further limiting innovation and market entry.

Market Opportunities

Expanding Applications in Non-Neurological Disorders

One of the significant market opportunities for the global Gamma Knife devices is the expanding scope of its applications beyond traditional neurological disorders. While Gamma Knife technology has primarily been used for treating brain tumors, arteriovenous malformations (AVMs), and other neurological conditions, its potential for treating tumors in other parts of the body, as well as functional disorders like Parkinson’s disease and epilepsy, is gaining attention. As advancements in precision and imaging technology continue, Gamma Knife is increasingly being considered for Stereotactic Radiosurgery (SRS) procedures in non-neurological fields. This broadening of its application areas creates new market segments, driving growth and adoption in various medical specialties. With continuous research and clinical trials demonstrating its efficacy in treating a wider array of disorders, Gamma Knife devices can establish themselves as a versatile tool in modern medicine.

Growing Healthcare Infrastructure and Emerging Markets

Another promising opportunity lies in the development of healthcare infrastructure in emerging economies. As countries in Asia, Latin America, and Africa invest heavily in improving healthcare access and quality, the demand for advanced medical technologies like Gamma Knife devices is increasing. Governments in these regions are committed to upgrading their medical facilities, which creates a substantial market for cutting-edge equipment. Furthermore, rising healthcare expenditures and an increasing focus on quality care are likely to drive further investments in Gamma Knife technology. This trend is bolstered by a growing awareness of minimally invasive treatment options and the desire for effective, targeted therapies. As healthcare systems in these regions continue to modernize, the adoption of Gamma Knife devices presents significant growth opportunities for manufacturers and healthcare providers.

Market Segmentation Analysis:

By Product Type:

The global Gamma Knife devices market is segmented by product type into portable and fixed devices. Portable Gamma Knife devices are gaining traction due to their mobility and ease of use in various healthcare settings, including smaller hospitals and specialized clinics. These devices offer greater flexibility, allowing for the treatment of patients in different locations and reducing the need for expensive infrastructure. On the other hand, fixed Gamma Knife devices are typically found in larger medical centers and hospitals due to their higher capacity for treating patients. They offer more robust capabilities, including advanced imaging and treatment precision. Both product types contribute to the market growth, with portable devices benefiting from increasing demand in emerging markets and fixed devices being preferred in regions with well-established healthcare infrastructure. The choice between the two types depends on the healthcare facility’s size, patient volume, and geographical location.

By Disease Indication:

The market for Gamma Knife devices is further segmented based on disease indications, including brain tumors, arteriovenous malformations (AVMs), trigeminal neuralgia, movement disorders, and others. Brain tumors remain the largest segment, as Gamma Knife radiosurgery is highly effective for treating various types of tumors with minimal side effects. Arteriovenous malformations (AVMs) are another significant application, where Gamma Knife offers a non-invasive solution to treat these complex vascular abnormalities. Trigeminal neuralgia and movement disorders like Parkinson’s disease are also growing areas, with Gamma Knife providing a promising alternative to traditional treatments. As the technology continues to advance, Gamma Knife devices are being increasingly applied to a wider range of neurological and functional disorders, driving the market’s expansion. The demand for targeted, minimally invasive treatments is expected to grow, further broadening the scope of Gamma Knife applications.

Segments:

Based on Product Type:

Portable Gamma Knife Devices
Fixed Gamma Knife Devices

Based on Disease Indication:

Brain Tumors
Arteriovenous Malformations (AVMs)
Trigeminal Neuralgia
Movement Disorders
Others

Based on End-User

Hospitals
Specialized Clinics
Ambulatory Surgery Centers (ASCs)

Based on the Geography:

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- France
- Germany
- Italy
- Spain
- Russia
- Belgium
- Netherlands
- Austria
- Sweden
- Poland
- Denmark
- Switzerland
- Rest of Europe
Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Thailand
- Indonesia
- Vietnam
- Malaysia
- Philippines
- Taiwan
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Peru
- Chile
- Colombia
- Rest of Latin America
Middle East
- UAE
- KSA
- Israel
- Turkey
- Iran
- Rest of Middle East
Africa
- Egypt
- Nigeria
- Algeria
- Morocco
- Rest of Africa

Regional Analysis

North America

North America holds the largest market share in the global Gamma Knife devices market, accounting for a significant portion of the revenue due to the well-established healthcare infrastructure and high demand for advanced medical technologies. The U.S. leads the region, driven by its robust healthcare system, high healthcare expenditure, and advanced treatment centers. The adoption of Gamma Knife technology is widespread across hospitals and specialized clinics, where it is used for treating neurological disorders, including brain tumors and arteriovenous malformations (AVMs). For instance, the University of Pittsburgh Medical Center (UPMC) has treated over 18,500 patients with Gamma Knife procedures, highlighting the extensive use of this technology in the U.S. This growth is supported by continuous advancements in Gamma Knife technology, an increasing preference for minimally invasive procedures, and rising awareness among healthcare providers and patients about the benefits of Gamma Knife therapy. Furthermore, the U.S. government’s healthcare initiatives and high levels of investment in medical technologies provide a favorable environment for market expansion.

Europe

Europe is the second-largest region in the global Gamma Knife devices market, with a market share of approximately 25% in 2023. The demand for Gamma Knife technology is growing steadily in European countries due to their strong healthcare infrastructure and government initiatives to enhance medical facilities. Countries such as Germany, the UK, and France are prominent adopters of Gamma Knife devices, driven by the rising prevalence of neurological disorders like brain tumors and trigeminal neuralgia. In addition, the European market is benefiting from technological advancements in Gamma Knife devices, such as improved precision and reduced treatment times, which enhance patient outcomes and treatment efficiency. The European Union’s investments in healthcare and the region’s aging population are key drivers of market growth, as there is a higher demand for effective, non-invasive treatments. With an increasing focus on improving healthcare accessibility and quality, Europe is expected to maintain a strong presence in the Gamma Knife devices market.

Asia-Pacific

The Asia-Pacific (APAC) region is experiencing rapid growth in the Gamma Knife devices market, with countries like China, Japan, India, and South Korea emerging as key players. The market share in APAC is expected to grow significantly due to the rising demand for advanced medical technologies in emerging economies and the expansion of healthcare infrastructure. Japan remains a dominant player in the region due to its high healthcare standards and early adoption of cutting-edge medical technologies. For instance, the 9th Asian Leksell Gamma Knife Society Meeting in Singapore highlighted the latest advancements and innovations in Gamma Knife radiosurgery, showcasing the region’s commitment to adopting advanced medical technologies. Meanwhile, countries such as China and India are increasingly investing in healthcare to address the growing burden of neurological disorders, creating opportunities for Gamma Knife devices. With a large patient pool and a shift towards minimally invasive treatments, the APAC market is poised for continued expansion. By 2032, APAC is expected to capture around 20% of the global market share, driven by rising healthcare investments, technological advancements, and increasing awareness.

Latin America and the Middle East & Africa

Latin America and the Middle East & Africa (MEA) present emerging opportunities for Gamma Knife device adoption, albeit from a smaller market share perspective. In Latin America, countries like Brazil and Mexico are experiencing gradual market growth, driven by increased healthcare investments and expanding access to advanced treatment options. The growing prevalence of neurological disorders in these regions is fostering demand for Gamma Knife technologies. In the MEA region, countries such as the UAE and Saudi Arabia are focusing on modernizing healthcare infrastructure, which is likely to boost the demand for Gamma Knife devices. The market share in these regions is currently low but is expected to rise steadily in the coming years due to government initiatives and the growing adoption of non-invasive medical technologies. By 2032, both regions are expected to contribute collectively to around 10-15% of the global market share.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Elekta AB
Varian Medical Systems, Inc. (A Siemens Healthineers Company)
Accuray Incorporated
Philips Healthcare
Brainlab AG
GE Healthcare
IBA (Ion Beam Applications S.A.)
Medtronic plc
Zap Surgical Systems, Inc.
Hitachi, Ltd.

Competitive Analysis

The global Gamma Knife devices market is highly competitive, with several prominent players driving innovation and market growth. Leading companies include Elekta AB, Varian Medical Systems (Siemens Healthineers), Accuray Incorporated, Philips Healthcare, Brainlab AG, GE Healthcare, IBA (Ion Beam Applications S.A.), Medtronic plc, Zap Surgical Systems, and Hitachi Ltd. Companies in the market are continuously investing in research and development to enhance the capabilities of Gamma Knife systems. For instance, Elekta’s recent introduction of the Gamma Knife Esprit has significantly improved precision and reduced treatment times, making it a preferred choice for treating complex neurological conditions. Technological advancements such as improved precision, reduced treatment times, and integration with advanced imaging technologies are key strategies for companies to differentiate their offerings. Moreover, the market is seeing increased collaborations, partnerships, and mergers, as companies seek to expand their product portfolios and improve geographical penetration. Strategic partnerships allow companies to integrate complementary technologies and offer comprehensive treatment solutions. This collaborative approach is critical in enhancing treatment efficacy and improving patient outcomes, which in turn drives demand for advanced systems like Gamma Knife devices. Despite the growth opportunities, the market faces several challenges, including high device costs, limited reimbursement policies, and regulatory hurdles. Companies are focusing on addressing these issues by developing cost-effective solutions and seeking regulatory approvals for new product innovations. As demand for minimally invasive treatments continues to rise, the competitive dynamics in the Gamma Knife devices market are expected to intensify.

Recent Developments

In June 2024, Fortis Memorial Research Institute introduced the Gamma Knife Esprit, marking the debut of this Leksell Gamma Knife in South Asia. According to the hospital, this state-of-the-art technology represents a new era in non-surgical, high-precision treatment for brain tumors, significantly expanding therapeutic options for both malignant and benign brain tumors, as well as other brain abnormalities.
In April 2024, the AdventHealth Neuroscience Institute became the first facility in Central Florida to use the Elekta Esprit Gamma Knife for treating brain patients. This cutting-edge stereotactic radiosurgery (SRS) system provides highly precise ablative radiation to targeted areas in the brain while minimizing exposure to surrounding healthy tissue.
In 2023, Elekta announced the launch of its new Elekta Esprit gamma knife system. The system features faster treatment planning, improved accuracy, and a more user friendly interface.
In May 2022, Elekta launched new radiosurgery system, Elekta Esprit. This next-generation gamma knife enable more personalized radiosurgery with sub-millimeter accuracy and treatment planning in less than 60 seconds. Esprit also offers clinicians superior visualization, as well as remote accessibility and collaboration tools for the treatment team. This product launch helped the company in augmenting its gamma knife product portfolio.

Market Concentration & Characteristics

The global Gamma Knife devices market exhibits moderate to high market concentration, with a few dominant players holding a significant share of the market. This concentration is primarily due to the high capital investment required for manufacturing and maintaining Gamma Knife systems, along with the advanced technological capabilities needed to remain competitive. These leading players focus on continuous product innovation, such as improving precision, reducing treatment times, and enhancing imaging technologies, to maintain their market position. As a result, the market is characterized by intense competition among established players, along with occasional mergers, acquisitions, and strategic partnerships to expand technological offerings and market reach. The market is also characterized by a growing demand for minimally invasive procedures, which has further encouraged innovation and development of Gamma Knife systems. The increasing prevalence of neurological disorders, such as brain tumors, arteriovenous malformations, and trigeminal neuralgia, is driving the adoption of these advanced devices. Additionally, the demand for non-invasive and precise treatments, coupled with shorter recovery times, is fueling market growth. Despite high entry barriers, some smaller players are also emerging with cost-effective solutions, leading to a more competitive and evolving market landscape. As the demand for advanced medical technologies grows, the market is expected to experience further consolidation.

Report Coverage

The research report offers an in-depth analysis based on Product Type, Disease Indication, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The global Gamma Knife devices market is expected to witness continued growth, driven by advancements in technology and increasing demand for minimally invasive procedures.
Technological innovations, including enhanced precision and shorter treatment times, will likely lead to increased adoption of Gamma Knife devices in clinical settings.
Growing prevalence of neurological disorders, such as brain tumors and arteriovenous malformations, will drive further demand for Gamma Knife treatment.
The shift towards outpatient and ambulatory care settings is expected to expand the market, as Gamma Knife devices offer non-invasive treatments with quicker recovery times.
Emerging markets in Asia-Pacific, Latin America, and the Middle East will contribute significantly to market expansion due to increasing healthcare infrastructure and investment.
The integration of Gamma Knife systems with advanced imaging technologies will continue to improve treatment planning and monitoring capabilities.
Rising healthcare expenditure and government initiatives to improve healthcare access will support the growth of Gamma Knife technology in various regions.
Increasing awareness among patients and healthcare providers about the benefits of Gamma Knife treatment will drive market acceptance.
Regulatory advancements and approval processes will impact market growth, with stricter regulations possibly slowing down the introduction of new technologies.
The development of portable Gamma Knife devices could open new opportunities for the treatment of neurological disorders in less accessible regions.

CHAPTER NO. 1 : INTRODUCTION 30

1.1.1. Report Description 30

Purpose of the Report 30

USP & Key Offerings 30

1.1.2. Key Benefits for Stakeholders 30

1.1.3. Target Audience 31

1.1.4. Report Scope 31

1.1.5. Regional Scope 32

CHAPTER NO. 2 : EXECUTIVE SUMMARY 33

2.1. Gamma Knife Devices Market Snapshot 33

2.1.1. Global Gamma Knife Devices Market, 2018 – 2032 (USD Million) 33

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 35

3.1. Russia-Ukraine and Israel-Palestine War Impacts 35

CHAPTER NO. 4 : GAMMA KNIFE DEVICES MARKET – INDUSTRY ANALYSIS 36

4.1. Introduction 36

4.2. Market Drivers 37

4.2.1. Rising Prevalence of Neurological Disorders 37

4.2.2. Technological Advancements in Gamma Knife Devices 38

4.3. Market Restraints 39

4.3.1. High Initial Costs and Maintenance 39

4.4. Market Opportunities 40

4.4.1. Growing Demand in Emerging Markets 40

4.5. Porter’s Five Forces Analysis 41

4.6. Value Chain Analysis 42

4.7. Buying Criteria 43

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 44

5.1. Import Analysis by Region 44

5.1.1. Global Gamma Knife Devices Market Import Volume/Revenue, By Region, 2018 – 2023 44

5.2. Export Analysis by Region 45

5.2.1. Global Gamma Knife Devices Market Export Volume/Revenue, By Region, 2018 – 2023 45

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 46

6.1. Demand Analysis by Region 46

6.1.1. Global Gamma Knife Devices Market Demand Volume/Revenue, By Region, 2018 – 2023 46

6.2. Supply Analysis by Region 47

6.2.1. Global Gamma Knife Devices Market Supply Volume/Revenue, By Region, 2018 – 2023 47

CHAPTER NO. 7 : PRODUCTION ANALYSIS 48

7.1. Production Analysis by Region 48

7.1.1. Global Gamma Knife Devices Market Production Volume/Revenue, By Region, 2018 – 2023 48

CHAPTER NO. 8 : PRICE ANALYSIS 49

8.1. Price Analysis by Region 49

8.1.1. Global Gamma Knife Devices Market Price, By Region, 2018 – 2023 49

8.1.2. Global Product Type Market Price, By Region, 2018 – 2023 49

8.2. Price Analysis by Product Type 50

8.2.1. Global Gamma Knife Devices Market Price, By Product Type, 2018 – 2023 50

8.2.2. Global Product Type Market Price, By Product Type, 2018 – 2023 50

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 51

9.1. Key Raw Materials and Suppliers 51

9.2. Key Raw Materials Price Trend 51

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 52

10.1. Manufacturing Cost Analysis 52

10.2. Manufacturing Process 52

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 53

11.1. Company Market Share Analysis – 2023 53

11.1.1. Global Gamma Knife Devices Market: Company Market Share, by Volume, 2023 53

11.1.2. Global Gamma Knife Devices Market: Company Market Share, by Revenue, 2023 54

11.1.3. Global Gamma Knife Devices Market: Top 6 Company Market Share, by Revenue, 2023 54

11.1.4. Global Gamma Knife Devices Market: Top 3 Company Market Share, by Revenue, 2023 55

11.2. Global Gamma Knife Devices Market Company Volume Market Share, 2023 56

11.3. Global Gamma Knife Devices Market Company Revenue Market Share, 2023 57

11.4. Company Assessment Metrics, 2023 57

11.4.1. Stars 57

11.4.2. Emerging Leaders 57

11.4.3. Pervasive Players 57

11.4.4. Participants 57

11.5. Start-ups /SMEs Assessment Metrics, 2023 57

11.5.1. Progressive Companies 57

11.5.2. Responsive Companies 58

11.5.3. Dynamic Companies 58

11.5.4. Starting Blocks 58

11.6. Strategic Developments 59

11.6.1. Acquisitions & Mergers 59

New Product Launch 59

Regional Expansion 59

11.7. Key Players Product Matrix 60

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 61

12.1. PESTEL 61

12.1.1. Political Factors 61

12.1.2. Economic Factors 61

12.1.3. Social Factors 61

12.1.4. Technological Factors 61

12.1.5. Environmental Factors 61

12.1.6. Legal Factors 61

12.2. Adjacent Market Analysis 61

CHAPTER NO. 13 : GAMMA KNIFE DEVICES MARKET – BY PRODUCT TYPE SEGMENT ANALYSIS 62

13.1. Gamma Knife Devices Market Overview, by Product Type Segment 62

13.1.1. Gamma Knife Devices Market Revenue Share, By Product Type, 2023 & 2032 63

13.1.2. Gamma Knife Devices Market Attractiveness Analysis, By Product Type 64

13.1.3. Incremental Revenue Growth Opportunity, by Product Type, 2024 – 2032 64

13.1.4. Gamma Knife Devices Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 65

13.2. Portable Gamma Knife Devices 66

13.2.1. Global Portable Gamma Knife Devices Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 67

13.2.2. Global Portable Gamma Knife Devices Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 67

13.3. Fixed Gamma Knife Devices 68

13.3.1. Global Fixed Gamma Knife Devices Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 69

13.3.2. Global Fixed Gamma Knife Devices Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 69

CHAPTER NO. 14 : GAMMA KNIFE DEVICES MARKET – BY DISEASE INDICATION SEGMENT ANALYSIS 70

14.1. Gamma Knife Devices Market Overview, by Disease Indication Segment 70

14.1.1. Gamma Knife Devices Market Revenue Share, By Disease Indication, 2023 & 2032 71

14.1.2. Gamma Knife Devices Market Attractiveness Analysis, By Disease Indication 72

14.1.3. Incremental Revenue Growth Opportunity, by Disease Indication, 2024 – 2032 72

14.1.4. Gamma Knife Devices Market Revenue, By Disease Indication, 2018, 2023, 2027 & 2032 73

14.2. Brain Tumors 74

14.2.1. Global Brain Tumors Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 75

14.2.2. Global Brain Tumors Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 75

14.3. Arteriovenous Malformations (AVMs) 76

14.3.1. Global Arteriovenous Malformations (AVMs) Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 77

14.3.2. Global Arteriovenous Malformations (AVMs) Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 77

14.4. Trigeminal Neuralgia 78

14.4.1. Global Trigeminal Neuralgia Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 79

14.4.2. Global Trigeminal Neuralgia Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 79

14.5. Movement Disorders 80

14.5.1. Global Movement Disorders Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 81

14.5.2. Global Movement Disorders Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 81

14.6. Others 82

14.6.1. Global Others Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 83

14.6.2. Global Others Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 83

CHAPTER NO. 15 : GAMMA KNIFE DEVICES MARKET – BY END-USER SEGMENT ANALYSIS 84

15.1. Gamma Knife Devices Market Overview, by End-user Segment 84

15.1.1. Gamma Knife Devices Market Revenue Share, By End-user, 2023 & 2032 85

15.1.2. Gamma Knife Devices Market Attractiveness Analysis, By End-user 86

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 86

15.1.4. Gamma Knife Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 87

15.2. Hospitals 88

15.2.1. Global Hospitals Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 89

15.2.2. Global Hospitals Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 89

15.3. Specialized Clinics 90

15.3.1. Global Specialized Clinics Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 91

15.3.2. Global Specialized Clinics Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 91

15.4. Ambulatory Surgery Centers (ASCs) 92

15.4.1. Global Ambulatory Surgery Centers (ASCs) Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 93

15.4.2. Global Ambulatory Surgery Centers (ASCs) Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 93

CHAPTER NO. 16 : GAMMA KNIFE DEVICES MARKET – REGIONAL ANALYSIS 94

16.1. Gamma Knife Devices Market Overview, by Regional Segments 94

16.2. Region 95

16.2.1. Global Gamma Knife Devices Market Revenue Share, By Region, 2023 & 2032 95

16.2.2. Gamma Knife Devices Market Attractiveness Analysis, By Region 96

16.2.3. Incremental Revenue Growth Opportunity, by Region, 2024 – 2032 96

16.2.4. Gamma Knife Devices Market Revenue, By Region, 2018, 2023, 2027 & 2032 97

16.2.5. Global Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 98

16.2.6. Global Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 98

16.3. Product Type 99

16.3.1. Global Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 99

16.4. Global Gamma Knife Devices Market Revenue, By Product Type, 2024 – 2032 (USD Million) 99

16.5. Disease Indication 100

16.5.1. Global Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 100

16.5.2. Global Gamma Knife Devices Market Revenue, By Disease Indication, 2024 – 2032 (USD Million) 100

16.6. End-user 101

16.6.1. Global Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 101

16.6.2. Global Gamma Knife Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 101

CHAPTER NO. 17 : GAMMA KNIFE DEVICES MARKET – NORTH AMERICA 102

17.1. North America 102

17.1.1. Key Highlights 102

17.1.2. North America Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 103

17.1.3. North America Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 104

17.1.4. North America Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 105

17.1.5. North America Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 106

17.2. U.S. 107

17.3. Canada 107

17.4. Mexico 107

CHAPTER NO. 18 : GAMMA KNIFE DEVICES MARKET – EUROPE 108

18.1. Europe 108

18.1.1. Key Highlights 108

18.1.2. Europe Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 109

18.1.3. Europe Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 110

18.1.4. Europe Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 111

18.1.5. Europe Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 112

18.2. UK 113

18.3. France 113

18.4. Germany 113

18.5. Italy 113

18.6. Spain 113

18.7. Russia 113

18.8. Belgium 113

18.9. Netherland 113

18.10. Austria 113

18.11. Sweden 113

18.12. Poland 113

18.13. Denmark 113

18.14. Switzerland 113

18.15. Rest of Europe 113

CHAPTER NO. 19 : GAMMA KNIFE DEVICES MARKET – ASIA PACIFIC 114

19.1. Asia Pacific 114

19.1.1. Key Highlights 114

19.1.2. Asia Pacific Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 115

19.1.3. Asia Pacific Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 116

19.1.4. Asia Pacific Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 117

19.1.5. Asia Pacific Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 118

19.2. China 119

19.3. Japan 119

19.4. South Korea 119

19.5. India 119

19.6. Australia 119

19.7. Thailand 119

19.8. Indonesia 119

19.9. Vietnam 119

19.10. Malaysia 119

19.11. Philippines 119

19.12. Taiwan 119

19.13. Rest of Asia Pacific 119

CHAPTER NO. 20 : GAMMA KNIFE DEVICES MARKET – LATIN AMERICA 120

20.1. Latin America 120

20.1.1. Key Highlights 120

20.1.2. Latin America Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 121

20.1.3. Latin America Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 122

20.1.4. Latin America Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 123

20.1.5. Latin America Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 124

20.2. Brazil 125

20.3. Argentina 125

20.4. Peru 125

20.5. Chile 125

20.6. Colombia 125

20.7. Rest of Latin America 125

CHAPTER NO. 21 : GAMMA KNIFE DEVICES MARKET – MIDDLE EAST 126

21.1. Middle East 126

21.1.1. Key Highlights 126

21.1.2. Middle East Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 127

21.1.3. Middle East Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 128

21.1.4. Middle East Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 129

21.1.5. Middle East Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 130

21.2. UAE 131

21.3. KSA 131

21.4. Israel 131

21.5. Turkey 131

21.6. Iran 131

21.7. Rest of Middle East 131

CHAPTER NO. 22 : GAMMA KNIFE DEVICES MARKET – AFRICA 132

22.1. Africa 132

22.1.1. Key Highlights 132

22.1.2. Africa Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 133

22.1.3. Africa Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 134

22.1.4. Africa Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 135

22.1.5. Africa Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 136

22.2. Egypt 137

22.3. Nigeria 137

22.4. Algeria 137

22.5. Morocco 137

22.6. Rest of Africa 137

CHAPTER NO. 23 : COMPANY PROFILES 138

23.1. Elekta AB 138

23.1.1. Company Overview 138

23.1.2. Product Portfolio 138

23.1.3. Swot Analysis 138

23.1.4. Business Strategy 139

23.1.5. Financial Overview 139

23.2. Varian Medical Systems, Inc. (A Siemens Healthineers Company) 140

23.3. Accuray Incorporated 140

23.4. Philips Healthcare 140

23.5. Brainlab AG 140

23.6. GE Healthcare 140

23.7. IBA (Ion Beam Applications S.A.) 140

23.8. Medtronic plc 140

23.9. Zap Surgical Systems, Inc. 140

23.10. Hitachi, Ltd. 140

List of Figures

FIG NO. 1. Global Gamma Knife Devices Market Revenue, 2018 – 2032 (USD Million) 32

FIG NO. 2. Porter’s Five Forces Analysis for Global Gamma Knife Devices Market 40

FIG NO. 3. Value Chain Analysis for Global Gamma Knife Devices Market 41

FIG NO. 4. Global Gamma Knife Devices Market Import Volume/Revenue, By Region, 2018 – 2023 43

FIG NO. 5. Global Gamma Knife Devices Market Export Volume/Revenue, By Region, 2018 – 2023 44

FIG NO. 6. Global Gamma Knife Devices Market Demand Volume/Revenue, By Region, 2018 – 2023 45

FIG NO. 7. Global Gamma Knife Devices Market Supply Volume/Revenue, By Region, 2018 – 2023 46

FIG NO. 8. Global Gamma Knife Devices Market Production Volume/Revenue, By Region, 2018 – 2023 47

FIG NO. 9. Global Gamma Knife Devices Market Price, By Region, 2018 – 2023 48

FIG NO. 10. Global Gamma Knife Devices Market Price, By Product Type, 2018 – 2023 49

FIG NO. 11. Raw Materials Price Trend Analysis, 2018 – 2023 50

FIG NO. 12. Manufacturing Cost Analysis 51

FIG NO. 13. Manufacturing Process 51

FIG NO. 14. Company Share Analysis, 2023 52

FIG NO. 15. Company Share Analysis, 2023 53

FIG NO. 16. Company Share Analysis, 2023 53

FIG NO. 17. Company Share Analysis, 2023 54

FIG NO. 18. Gamma Knife Devices Market – Company Volume Market Share, 2023 55

FIG NO. 19. Gamma Knife Devices Market – Company Revenue Market Share, 2023 56

FIG NO. 20. Gamma Knife Devices Market Revenue Share, By Product Type, 2023 & 2032 62

FIG NO. 21. Market Attractiveness Analysis, By Product Type 63

FIG NO. 22. Incremental Revenue Growth Opportunity by Product Type, 2024 – 2032 63

FIG NO. 23. Gamma Knife Devices Market Revenue, By Product Type, 2018, 2023, 2027 & 2032 64

FIG NO. 24. Global Gamma Knife Devices Market for Portable Gamma Knife Devices, Revenue (USD Million) 2018 – 2032 65

FIG NO. 25. Global Gamma Knife Devices Market for Fixed Gamma Knife Devices, Revenue (USD Million) 2018 – 2032 67

FIG NO. 26. Gamma Knife Devices Market Revenue Share, By Disease Indication, 2023 & 2032 70

FIG NO. 27. Market Attractiveness Analysis, By Disease Indication 71

FIG NO. 28. Incremental Revenue Growth Opportunity by Disease Indication, 2024 – 2032 71

FIG NO. 29. Gamma Knife Devices Market Revenue, By Disease Indication, 2018, 2023, 2027 & 2032 72

FIG NO. 30. Global Gamma Knife Devices Market for Brain Tumors, Revenue (USD Million) 2018 – 2032 73

FIG NO. 31. Global Gamma Knife Devices Market for Arteriovenous Malformations (AVMs), Revenue (USD Million) 2018 – 2032 75

FIG NO. 32. Global Gamma Knife Devices Market for Trigeminal Neuralgia, Revenue (USD Million) 2018 – 2032 77

FIG NO. 33. Global Gamma Knife Devices Market for Movement Disorders, Revenue (USD Million) 2018 – 2032 79

FIG NO. 34. Global Gamma Knife Devices Market for Others, Revenue (USD Million) 2018 – 2032 81

FIG NO. 35. Gamma Knife Devices Market Revenue Share, By End-user, 2023 & 2032 84

FIG NO. 36. Market Attractiveness Analysis, By End-user 85

FIG NO. 37. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 85

FIG NO. 38. Gamma Knife Devices Market Revenue, By End-user, 2018, 2023, 2027 & 2032 86

FIG NO. 39. Global Gamma Knife Devices Market for Hospitals, Revenue (USD Million) 2018 – 2032 87

FIG NO. 40. Global Gamma Knife Devices Market for Specialized Clinics, Revenue (USD Million) 2018 – 2032 89

FIG NO. 41. Global Gamma Knife Devices Market for Ambulatory Surgery Centers (ASCs), Revenue (USD Million) 2018 – 2032 91

FIG NO. 42. Global Gamma Knife Devices Market Revenue Share, By Region, 2023 & 2032 94

FIG NO. 43. Market Attractiveness Analysis, By Region 95

FIG NO. 44. Incremental Revenue Growth Opportunity by Region, 2024 – 2032 95

FIG NO. 45. Gamma Knife Devices Market Revenue, By Region, 2018, 2023, 2027 & 2032 96

FIG NO. 46. North America Gamma Knife Devices Market Revenue, 2018 – 2032 (USD Million) 101

FIG NO. 47. Europe Gamma Knife Devices Market Revenue, 2018 – 2032 (USD Million) 107

FIG NO. 48. Asia Pacific Gamma Knife Devices Market Revenue, 2018 – 2032 (USD Million) 113

FIG NO. 49. Latin America Gamma Knife Devices Market Revenue, 2018 – 2032 (USD Million) 119

FIG NO. 50. Middle East Gamma Knife Devices Market Revenue, 2018 – 2032 (USD Million) 125

FIG NO. 51. Africa Gamma Knife Devices Market Revenue, 2018 – 2032 (USD Million) 131

List of Tables

TABLE NO. 1. : Global Gamma Knife Devices Market: Snapshot 30

TABLE NO. 2. : Drivers for the Gamma Knife Devices Market: Impact Analysis 34

TABLE NO. 3. : Restraints for the Gamma Knife Devices Market: Impact Analysis 36

TABLE NO. 4. : Global Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 46

TABLE NO. 5. : Global Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 47

TABLE NO. 6. : Key Raw Materials & Suppliers 48

TABLE NO. 7. : Global Portable Gamma Knife Devices Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 64

TABLE NO. 8. : Global Portable Gamma Knife Devices Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 64

TABLE NO. 9. : Global Fixed Gamma Knife Devices Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 66

TABLE NO. 10. : Global Fixed Gamma Knife Devices Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 66

TABLE NO. 11. : Global Brain Tumors Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 72

TABLE NO. 12. : Global Brain Tumors Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 72

TABLE NO. 13. : Global Arteriovenous Malformations (AVMs) Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 74

TABLE NO. 14. : Global Arteriovenous Malformations (AVMs) Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 74

TABLE NO. 15. : Global Trigeminal Neuralgia Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 76

TABLE NO. 16. : Global Trigeminal Neuralgia Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 76

TABLE NO. 17. : Global Movement Disorders Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 78

TABLE NO. 18. : Global Movement Disorders Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 78

TABLE NO. 19. : Global Others Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 80

TABLE NO. 20. : Global Others Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 80

TABLE NO. 21. : Global Hospitals Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 86

TABLE NO. 22. : Global Hospitals Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 86

TABLE NO. 23. : Global Specialized Clinics Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 88

TABLE NO. 24. : Global Specialized Clinics Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 88

TABLE NO. 25. : Global Ambulatory Surgery Centers (ASCs) Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 90

TABLE NO. 26. : Global Ambulatory Surgery Centers (ASCs) Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 90

TABLE NO. 27. : Global Gamma Knife Devices Market Revenue, By Region, 2018 – 2023 (USD Million) 95

TABLE NO. 28. : Global Gamma Knife Devices Market Revenue, By Region, 2024 – 2032 (USD Million) 95

TABLE NO. 29. : Global Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 96

TABLE NO. 30. : Global Gamma Knife Devices Market Revenue, By Product Type, 2024 – 2032 (USD Million) 96

TABLE NO. 31. : Global Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 97

TABLE NO. 32. : Global Gamma Knife Devices Market Revenue, By Disease Indication, 2024 – 2032 (USD Million) 97

TABLE NO. 33. : Global Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 98

TABLE NO. 34. : Global Gamma Knife Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 98

TABLE NO. 35. : North America Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 100

TABLE NO. 36. : North America Gamma Knife Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 100

TABLE NO. 37. : North America Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 101

TABLE NO. 38. : North America Gamma Knife Devices Market Revenue, By Product Type, 2024 – 2032 (USD Million) 101

TABLE NO. 39. : North America Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 102

TABLE NO. 40. : North America Gamma Knife Devices Market Revenue, By Disease Indication, 2024 – 2032 (USD Million) 102

TABLE NO. 41. : North America Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 103

TABLE NO. 42. : North America Gamma Knife Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 103

TABLE NO. 43. : Europe Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 106

TABLE NO. 44. : Europe Gamma Knife Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 106

TABLE NO. 45. : Europe Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 107

TABLE NO. 46. : Europe Gamma Knife Devices Market Revenue, By Product Type, 2024 – 2032 (USD Million) 107

TABLE NO. 47. : Europe Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 108

TABLE NO. 48. : Europe Gamma Knife Devices Market Revenue, By Disease Indication, 2024 – 2032 (USD Million) 108

TABLE NO. 49. : Europe Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 109

TABLE NO. 50. : Europe Gamma Knife Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 109

TABLE NO. 51. : Asia Pacific Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 112

TABLE NO. 52. : Asia Pacific Gamma Knife Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 112

TABLE NO. 53. : Asia Pacific Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 113

TABLE NO. 54. : Asia Pacific Gamma Knife Devices Market Revenue, By Product Type, 2024 – 2032 (USD Million) 113

TABLE NO. 55. : Asia Pacific Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 114

TABLE NO. 56. : Asia Pacific Gamma Knife Devices Market Revenue, By Disease Indication, 2024 – 2032 (USD Million) 114

TABLE NO. 57. : Asia Pacific Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 115

TABLE NO. 58. : Asia Pacific Gamma Knife Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 115

TABLE NO. 59. : Latin America Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 118

TABLE NO. 60. : Latin America Gamma Knife Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 118

TABLE NO. 61. : Latin America Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 119

TABLE NO. 62. : Latin America Gamma Knife Devices Market Revenue, By Product Type, 2024 – 2032 (USD Million) 119

TABLE NO. 63. : Latin America Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 120

TABLE NO. 64. : Latin America Gamma Knife Devices Market Revenue, By Disease Indication, 2024 – 2032 (USD Million) 120

TABLE NO. 65. : Latin America Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 121

TABLE NO. 66. : Latin America Gamma Knife Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 121

TABLE NO. 67. : Middle East Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 124

TABLE NO. 68. : Middle East Gamma Knife Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 124

TABLE NO. 69. : Middle East Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 125

TABLE NO. 70. : Middle East Gamma Knife Devices Market Revenue, By Product Type, 2024 – 2032 (USD Million) 125

TABLE NO. 71. : Middle East Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 126

TABLE NO. 72. : Middle East Gamma Knife Devices Market Revenue, By Disease Indication, 2024 – 2032 (USD Million) 126

TABLE NO. 73. : Middle East Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 127

TABLE NO. 74. : Middle East Gamma Knife Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 127

TABLE NO. 75. : Africa Gamma Knife Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 130

TABLE NO. 76. : Africa Gamma Knife Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 130

TABLE NO. 77. : Africa Gamma Knife Devices Market Revenue, By Product Type, 2018 – 2023 (USD Million) 131

TABLE NO. 78. : Africa Gamma Knife Devices Market Revenue, By Product Type, 2024 – 2032 (USD Million) 131

TABLE NO. 79. : Africa Gamma Knife Devices Market Revenue, By Disease Indication, 2018 – 2023 (USD Million) 132

TABLE NO. 80. : Africa Gamma Knife Devices Market Revenue, By Disease Indication, 2024 – 2032 (USD Million) 132

TABLE NO. 81. : Africa Gamma Knife Devices Market Revenue, By End-user, 2018 – 2023 (USD Million) 133

TABLE NO. 82. : Africa Gamma Knife Devices Market Revenue, By End-user, 2024 – 2032 (USD Million) 133

Frequently Asked Questions

What is the current size of the Global Gamma Knife Devices market?

The global Gamma Knife Devices market was valued at USD 543.91 million in 2023 and is projected to grow to USD 858.36 million by 2032, registering a compound annual growth rate (CAGR) of 5.20%.

What factors are driving the growth of the Global Gamma Knife Devices market?

The market growth is driven by the increasing prevalence of neurological disorders, such as brain tumors and arteriovenous malformations (AVMs), rising demand for minimally invasive procedures, and continuous technological advancements. Other factors include government initiatives to improve healthcare infrastructure and a growing preference for precise, targeted treatments with shorter recovery times.

What are the key segments within the Global Gamma Knife Devices market?

The key segments are based on product type (portable and fixed devices), disease indication (brain tumors, AVMs, trigeminal neuralgia, movement disorders, and others), end-users (hospitals, specialized clinics, and ambulatory surgery centers), and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).

What are some challenges faced by the Global Gamma Knife Devices market?

Challenges include the high cost of Gamma Knife systems, limited reimbursement policies in certain regions, and the complexity of installation and maintenance. Additionally, competition from alternative stereotactic radiosurgery systems, such as CyberKnife, and regulatory hurdles can impact market growth.

Who are the major players in the Global Gamma Knife Devices market?

Key players include Elekta AB, Varian Medical Systems (a Siemens Healthineers company), Accuray Incorporated, Philips Healthcare, Brainlab AG, GE Healthcare, IBA (Ion Beam Applications S.A.), Medtronic plc, Zap Surgical Systems, and Hitachi, Ltd. These companies focus on innovation, strategic partnerships, and expanding their global presence.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$12699

Let us help you

MIKE, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –